An Investigation of the Relationship Between the Enos Gene Polymorphism and Diagnosed Migraine

1. Borroni B, Rao R, Liberini P, Venturelli E, Cossandi M, Archetti S, et al. Endothelial nitric oxide synthase (Glu298Asp) polymorphism is an independent risk factor for migraine with aura. Headache. 2006; 46(10): 1575-1579.10.1111/j.1526-4610.2006.00614.x17115991Search in Google Scholar

2. Toriello M, Oterino A, Pascual J, Castillo J, Colás R, Alonso-Arranz A, et al. Lack of association of endothelial nitricoxide synthase polymorphisms and migraine. Headache. 2008; 48(7): 1115-1119.10.1111/j.1526-4610.2008.01181.x18687083Search in Google Scholar

3. Gruber HJ, Bernecker C, Lechner A, Weiss S, Wallner-Blazek m, Meinitzer A, et al. Increased nitric oxide stress is associated with migraine. Cephalalgia. 2010; 30(4): 486-492.10.1111/j.1468-2982.2009.01964.x19673897Search in Google Scholar

4. Gkaliagkousi E, Douma S, Zamboulis C, Ferro A. Nitric oxide dysfunction in vascular endothelium and platelets: Role in essential hypertension. J Hypertens. 2009; 27(12): 2310-2320.10.1097/HJH.0b013e328330e89a19838132Search in Google Scholar

5. Gonçalves FM, Martins-Oliveira A, Speciali JG, Luizon MR, Izidoro-Toledo TC, Silva PS, et al. Endothelial nitric oxide synthase haplotypes associated with aura in patients with migraine. DNA Cell Biol. 2011; 30(6): 363-369.10.1089/dna.2010.115221332392Search in Google Scholar

6. Headache Classification Committee, International Headache Society. The International Classification of Headache Disorders, 2nd ed. Cephalalgia. 2004; 24(1): 1-160.Search in Google Scholar

7. Stovner, L, Hagen, K, Jensen, R, Katsarava Z, Lipton R, Scher A, et al. The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27(3): 193-210.10.1111/j.1468-2982.2007.01288.x17381554Search in Google Scholar

8. Gonçalves FM, Luizon MR, Speciali JG, Martins- Oliveira A, Dach F, Tanus-Santos JE, et al. Interaction among nitric oxide (NO)-related genes in migraine susceptibility. Mol Cell Biochem. 2012; 370(1-2): 183-189.10.1007/s11010-012-1409-522865486Search in Google Scholar

9. Olesen J. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther. 2008; 120(2): 157-171.10.1016/j.pharmthera.2008.08.00318789357Search in Google Scholar

10. Olesen J. Nitric oxide-related drug targets in headache. Neurotherapeutics. 2010 7(2): 183-190.10.1016/j.nurt.2010.03.006508409920430317Search in Google Scholar

11. Sarchielli P, Floridi A, Mancini ML, Rossi C, Coppola F, Baldi A, et al. NF-κB Activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks. Cephalalgia. 2006; 26(9): 1071-1079.10.1111/j.1468-2982.2006.01164.x16919057Search in Google Scholar

12. de O S Mansur T, Gonçalves FM, Martins- Oliveira A, Speciali JG, Dach F, Lacchini R, et al. Inducible nitric oxide synthase haplotype associated with migraine and aura. Mol Cell Biochem. 2012; 364(1-2): 303-308.10.1007/s11010-012-1231-0Search in Google Scholar

13. Lea RA, Curtain RP, Shepherd AG, Brimage PJ, Griffiths LR. No evidence for involvement of the human inducible nitric oxide synthase (iNOS) gene in susceptibility to typical migraine. Am J Med Genet. 2001; 105(1): 110-113.10.1002/1096-8628(20010108)105:1<110::AID-AJMG1073>3.0.CO;2-#Search in Google Scholar

14. Jia S, Ni J, Chen S, Jiang Y, Dong W, Gao Y. Association of the pentanucleotide repeat polymorphism in NOS2 promoter region with susceptibility to migraine in a Chinese population. DNA Cell Biol. 2011; 30(2): 117-122.10.1089/dna.2010.1102Search in Google Scholar

15. Noseda R, Kainz V, Jakubowski M, Gooley JJ, Saper CB, Digre K, et al. A neural mechanism for exacerbation of headache by light. Nat Neurosci. 2010; 13(2): 239-245.10.1038/nn.2475Search in Google Scholar

16. Milhaud D, Bogousslavsky J, van Melle G, Liot P. Ischemic stroke and active migraine. Neurology. 2001; 57(10): 1805-1811.10.1212/WNL.57.10.1805Search in Google Scholar

17. Olesen J. Nitric oxide-related drug targets in headache. Neurotherapeutics. 2010; 7(2): 183-190.10.1016/j.nurt.2010.03.006Search in Google Scholar

18. Napoli R, Guardasole V, Zarra E, Matarazzo M, D’Anna C, Saccà F, et al. Vascular smooth muscle cell dysfunction in patients with migraine. Neurology. 2009; 72(24): 2111-2114.10.1212/WNL.0b013e3181aa53ceSearch in Google Scholar

19. Myers DE. Potential neurogenic and vascular roles of nitric oxide in migraine headache and aura. Headache. 1999; 39(2): 118-124.10.1046/j.1526-4610.1999.3902118.xSearch in Google Scholar

20. Tanus-Santos JE, Desai M, Flockhart DA. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics. 2001; 1(8): 719-725.10.1097/00008571-200111000-00011Search in Google Scholar

21. Crawford DC, Nickerson DA. Definition and clinical importance of haplotypes. Annu Rev Med. 2005; 56(1): 303-320.10.1146/annurev.med.56.082103.104540Search in Google Scholar

22. Metzger IF, Souza-Costa DC, Marroni AS, Nagassaki S, Desta Z, Flockhart DA, et al. Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics. 2005; 15(8): 565-570.10.1097/01.fpc.0000167328.85163.44Search in Google Scholar

23. Wang J, Dudley D, Wang XL. Haplotype-specific effects on endothelial NO synthase promoter efficiency: Modifiable by cigarette smoking. Arterioscler Thromb Vasc Biol. 2002; 22(5): e1-e4.10.1161/01.ATV.0000016248.51577.1FSearch in Google Scholar

24. Lauer T, Kleinbongard P, Kelm M. Indexes of NO bioavailability in human blood. News Physiol Sci. 2002; 17(6): 251-255.10.1152/nips.01405.2002Search in Google Scholar

25. Metzger IF, Sertorio JTC, Tanus-Santos JE. Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers. Acta Physiol. 2006; 188(2): 123-127.10.1111/j.1748-1716.2006.01612.xSearch in Google Scholar

26. Metzger IF, Sertório JT, Tanus-Santos JE. Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med. 2007; 43(6): 987-992.10.1016/j.freeradbiomed.2007.06.012Search in Google Scholar

27. Metzger IF, Ishizawa MH, Rios-Santos F, Carvalho WA, Tanus-Santos JE. Endothelial nitric oxide synthase gene haplotypes affect nitrite levels in black subjects. Phar-macogenomics J. 2011; 11(6): 393-399.10.1038/tpj.2010.52Search in Google Scholar

28. Metzger IF, Luizon MR, Lacchini R, Ishizawa MH, Tanus-Santos JE. Effects of endothelial nitric oxide synthase tagSNPs haplotypes on nitrite levels in Black subjects. Nitric Oxide. 2013; 28(1): 33-38.10.1016/j.niox.2012.10.002Search in Google Scholar

29. Sipahi T, Guldiken B, Kabayel L, Palabıyık O, Oskan H, Kılıç TO, et al. Endothelial nitric oxide synthase and angiotensin converting enzyme gene polymorphisms in migraine patients. Arch Neuropsychiatr. 2013; 50(1): 274-278. Search in Google Scholar

30. Guldiken B, Sipahi T, Guldiken S, Ustundag S, Budak M, Turgut N, et al. Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in Turkish patients with ischemic stroke. Mol Biol Rep. 2009; 36(6): 1539-1543.10.1007/s11033-008-9348-7Search in Google Scholar

31. Martelletti P, Lulli P, Morellini M, Mariani B, Pennesi G, Cappellacci S, et al. Chromosome 6pencoded HLA-DR2 determination discriminates migraine without aura from migraine with aura. Hum Immunol. 1999; 60(1): 69-74.10.1016/S0198-8859(98)00087-1Search in Google Scholar

32. Rainero I, Grimaldi LM, Salani G, Valfrè W, Rivoiro C, Savi L, et al. Association between the tumor necrosis factor-α -308 G/A gene polymorphism and migraine. Neurology. 2004; 62(1): 141-143.10.1212/01.WNL.0000101717.16799.8F14718719Search in Google Scholar

33. Rubino E, Fenoglio P, Gallone S, Govone F, Vacca A, De Martino P, et al. Genetic variants in the NOTCH4 gene influence the clinical features of migraine. J Headache Pain. 2013; 14(1): 28-32. 10.1186/1129-2377-14-28362043823566281Search in Google Scholar